Let's focus on what we can do!

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Diabetes
  • >
  • FDA to review Sanofi’s new diabetes combo – PharmaTimes

FDA to review Sanofi’s new diabetes combo – PharmaTimes

Wednesday, 24 February, 2016

FDA to review Sanofi’s new diabetes combo – PharmaTimes

Lixisenatide was cleared in Europe in 2013 as Lyxumia to help adults with type II diabetes achieve glycaemic control in combination with oral glucose-lowering medicinal products and/or basal insulin, but the drug is still under review in the US, with a ...

Read More

Source:FDA to review Sanofi's new diabetes combo - PharmaTimes

Categories :
  • Diabetes
  • Latest Headlines
  • Uncategorized
Socials :

Recent posts